Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics
Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $131.90 USD
5.35 (-3.90%)
Updated Jun 4 4:00pm
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALNY Stock Summary
- ALNY has a higher market value than 89.66% of US stocks; more precisely, its current market capitalization is $15,758,928,475.
- With a price/sales ratio of 55.11, Alnylam Pharmaceuticals Inc has a higher such ratio than 96.62% of stocks in our set.
- Revenue growth over the past 12 months for Alnylam Pharmaceuticals Inc comes in at 231.31%, a number that bests 97.13% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Alnylam Pharmaceuticals Inc, a group of peers worth examining would be MXIM, SWKS, GNTX, XLNX, and BGNE.
- ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.
ALNY Daily Price Range
ALNY 52-Week Price Range
ALNY Stock Price Chart More Charts
ALNY Price/Volume Stats
| Current price | $131.90 | 52-week high | $151.84 |
| Prev. close | $137.25 | 52-week low | $68.00 |
| Day low | $131.11 | Volume | 623,494 |
| Day high | $139.03 | Avg. volume | 794,266 |
| 50-day MA | $130.02 | Dividend yield | N/A |
| 200-day MA | $109.60 | Market Cap | 15.14B |
Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...